REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,415,358 | -53.1% | 1,082,420 | +3.6% | 0.00% | -60.0% |
| Q2 2023 | $26,456,264 | -28.0% | 1,045,289 | -8.4% | 0.01% | -28.6% |
| Q1 2023 | $36,756,763 | +53.8% | 1,141,160 | -11.9% | 0.01% | +40.0% |
| Q4 2022 | $23,899,701 | +166.1% | 1,294,675 | +289.2% | 0.01% | +150.0% |
| Q3 2022 | $8,983,000 | +88.7% | 332,677 | -3.4% | 0.00% | +100.0% |
| Q2 2022 | $4,760,000 | -29.2% | 344,467 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $6,723,000 | -60.3% | 344,788 | -66.8% | 0.00% | -66.7% |
| Q4 2021 | $16,955,000 | -50.0% | 1,038,912 | -14.6% | 0.00% | -50.0% |
| Q3 2021 | $33,908,000 | -58.7% | 1,217,093 | -56.1% | 0.01% | -57.1% |
| Q2 2021 | $82,109,000 | +3.6% | 2,770,240 | -2.3% | 0.01% | 0.0% |
| Q1 2021 | $79,257,000 | -14.4% | 2,835,691 | -13.2% | 0.01% | -17.6% |
| Q4 2020 | $92,619,000 | +3.4% | 3,268,117 | -8.3% | 0.02% | -10.5% |
| Q3 2020 | $89,563,000 | -2.4% | 3,562,591 | -5.2% | 0.02% | -5.0% |
| Q2 2020 | $91,741,000 | +10.2% | 3,756,798 | -33.2% | 0.02% | -9.1% |
| Q1 2020 | $83,271,000 | -11.4% | 5,626,419 | -2.8% | 0.02% | +10.0% |
| Q4 2019 | $93,940,000 | +33.5% | 5,788,045 | +7.0% | 0.02% | +25.0% |
| Q3 2019 | $70,349,000 | -4.9% | 5,411,472 | -5.1% | 0.02% | 0.0% |
| Q2 2019 | $73,973,000 | -18.3% | 5,703,467 | -0.7% | 0.02% | -23.8% |
| Q1 2019 | $90,528,000 | +4.3% | 5,744,134 | +33.2% | 0.02% | -4.5% |
| Q4 2018 | $86,787,000 | -13.0% | 4,311,344 | +7.4% | 0.02% | +4.8% |
| Q3 2018 | $99,781,000 | -3.9% | 4,015,343 | +6.2% | 0.02% | -8.7% |
| Q2 2018 | $103,833,000 | -11.6% | 3,782,587 | -0.8% | 0.02% | -14.8% |
| Q1 2018 | $117,472,000 | -8.0% | 3,814,034 | +6.7% | 0.03% | -3.6% |
| Q4 2017 | $127,740,000 | +98.0% | 3,573,150 | +52.6% | 0.03% | +86.7% |
| Q3 2017 | $64,508,000 | +26.0% | 2,341,510 | +20.7% | 0.02% | +25.0% |
| Q2 2017 | $51,212,000 | +17.7% | 1,939,812 | -7.3% | 0.01% | +20.0% |
| Q1 2017 | $43,510,000 | -2.2% | 2,091,807 | -2.7% | 0.01% | -9.1% |
| Q4 2016 | $44,499,000 | +13.8% | 2,149,678 | -10.9% | 0.01% | +10.0% |
| Q3 2016 | $39,120,000 | +23.0% | 2,413,340 | +3.2% | 0.01% | +25.0% |
| Q2 2016 | $31,805,000 | +10.3% | 2,338,548 | +41.6% | 0.01% | 0.0% |
| Q1 2016 | $28,834,000 | +62.0% | 1,651,426 | +216.9% | 0.01% | +60.0% |
| Q4 2015 | $17,803,000 | +570.3% | 521,178 | +484.0% | 0.01% | +400.0% |
| Q3 2015 | $2,656,000 | -23.5% | 89,242 | -17.8% | 0.00% | 0.0% |
| Q2 2015 | $3,474,000 | +55.5% | 108,622 | +0.8% | 0.00% | 0.0% |
| Q1 2015 | $2,234,000 | -17.7% | 107,762 | -32.7% | 0.00% | 0.0% |
| Q4 2014 | $2,714,000 | – | 160,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |